Literature DB >> 1148996

Primary carcinoma of the ureter: a prognostic study.

M A Batata, W F Whitmore, B S Hilaris, N Tokita, H Grabstald.   

Abstract

Fourty-one patients with primary invasive carcinomas of the ureter were seen at Memorial Hospital from 1947 to 1972. Overall survuval patterns were similiar in 19 patients with and 22 patients without prior or concomitant urothelial cancers elsewhere in the urinary tract, with 5-year survival rates, as estimated by the product-limit methos, of41% for both groups. Prognosis was determined primarily by anatomical stage of ureteral cancer. In 11 Stage A (submucosal) patients, 7 Stage B (muscular), 12 Stage C (periureteric fat), and 9Stage D (extraureteral), the similarly estimated 5-year survival rates were 91%, 43%, 23%, and nil, respectively. None of Stage A cases had metastases for periods ranging from 5 to 11 years after surgery alone. Seventy-eight percent of patients with more advanced stages died within 3 years of treatment, withmetastases mainly in pelvic and para-aortic lymph nodes.

Entities:  

Mesh:

Year:  1975        PMID: 1148996     DOI: 10.1002/1097-0142(197506)35:6<1626::aid-cncr2820350623>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Primary carcinoma of the renal pelvis and ureter. A collective review.

Authors:  Z Uysal; C Taşar; M Bakkaloğlu; D Remzi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

2.  High-grade invasive urothelial carcinoma of the ureter with systematic lymph node metastasis successfully treated by nephroureterectomy followed by chemotherapy.

Authors:  Zhu-Qing Liu; Xi Zhang; Qing Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

4.  Is CIS of the ureter responsible for skipped lymph node metastasis? A case report.

Authors:  K Kunimi; T Uchibayashi; H Yamamoto; T Hasegawa; Y Kadono; M Ohkawa
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 5.  The role of lymphadenectomy for upper tract urothelial carcinoma.

Authors:  Jamie Messer; Yu Kuan Lin; Jay D Raman
Journal:  Nat Rev Urol       Date:  2011-05-24       Impact factor: 14.432

6.  Current Status of Lymphadenectomy During Radical Nephroureterectomy for Upper Tract Urothelial Cancer-Yes, No or Maybe?

Authors:  Ashwin Sunil Tamhankar; Saurabh Ramesh Patil; Puneet Ahluwalia; Gagan Gautam
Journal:  Indian J Surg Oncol       Date:  2018-08-13

7.  Robotic nephroureterectomy with partial duodenectomy for invasive ureteral tumor.

Authors:  Pankaj P Dangle; Stephen Moore; Ronney Abaza
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

8.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10

9.  Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.

Authors:  Shilajit D Kundu; Scott E Eggener
Journal:  Adv Urol       Date:  2009-01-26

10.  Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.

Authors:  Kang Su Cho; Hyun Min Choi; Kyochul Koo; Sung Jin Park; Koon Ho Rha; Young Deuk Choi; Byung Ha Chung; Nam Hoon Cho; Seung Choul Yang; Sung Joon Hong
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.